NO993921L - Medikament mot infertilitet og for ökt fertilitet - Google Patents

Medikament mot infertilitet og for ökt fertilitet

Info

Publication number
NO993921L
NO993921L NO993921A NO993921A NO993921L NO 993921 L NO993921 L NO 993921L NO 993921 A NO993921 A NO 993921A NO 993921 A NO993921 A NO 993921A NO 993921 L NO993921 L NO 993921L
Authority
NO
Norway
Prior art keywords
infertility
medication
relates
increased fertility
pharmaceutical composition
Prior art date
Application number
NO993921A
Other languages
English (en)
Other versions
NO321663B1 (no
NO993921D0 (no
Inventor
Greta Edelstam
Original Assignee
Edelstam Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edelstam Inc filed Critical Edelstam Inc
Publication of NO993921D0 publication Critical patent/NO993921D0/no
Publication of NO993921L publication Critical patent/NO993921L/no
Publication of NO321663B1 publication Critical patent/NO321663B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
NO19993921A 1997-02-15 1999-08-13 Anvendelse av et lidokain for fremstilling av et preparat for a redusere fagocytose av spermatozoer. NO321663B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,737 US5977143A (en) 1997-02-15 1997-02-15 Medicament against infertility which reduces phagocytosis of spermatozoa in women
PCT/US1998/002267 WO1998035676A1 (en) 1997-02-15 1998-02-09 A medicament against infertility and for increasing fertility

Publications (3)

Publication Number Publication Date
NO993921D0 NO993921D0 (no) 1999-08-13
NO993921L true NO993921L (no) 1999-08-13
NO321663B1 NO321663B1 (no) 2006-06-19

Family

ID=25179227

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993921A NO321663B1 (no) 1997-02-15 1999-08-13 Anvendelse av et lidokain for fremstilling av et preparat for a redusere fagocytose av spermatozoer.

Country Status (23)

Country Link
US (1) US5977143A (no)
EP (1) EP1001771B1 (no)
JP (1) JP3497513B2 (no)
KR (1) KR20000071053A (no)
CN (1) CN1248915A (no)
AT (1) ATE295169T1 (no)
AU (1) AU743346B2 (no)
BR (1) BR9807370A (no)
CA (1) CA2280685C (no)
DE (1) DE69830176T2 (no)
EE (1) EE9900346A (no)
ES (1) ES2245022T3 (no)
HU (1) HUP0001342A3 (no)
IL (1) IL131267A0 (no)
IS (1) IS5152A (no)
LT (1) LT4661B (no)
LV (1) LV12450B (no)
NO (1) NO321663B1 (no)
NZ (1) NZ337504A (no)
PL (1) PL335419A1 (no)
SK (1) SK110599A3 (no)
TR (1) TR199901958T2 (no)
WO (1) WO1998035676A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249250T3 (es) * 1997-02-15 2006-04-01 Edelstam Inc. Medicamento contra la dismenorrea y el sindrome premenstrual que comprende lidocaina.
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US9849102B2 (en) 2010-05-19 2017-12-26 Isifer Ab Treatment for reducing inflammation
AU2016340769B2 (en) * 2015-10-23 2018-07-12 Isifer Ab Composition for treatment of infertility in a female subject
KR101802090B1 (ko) * 2016-09-26 2017-11-27 서울대학교산학협력단 탈락막 자궁내막 세포를 포함하는 자궁내막 손상의 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
FR2704147B1 (fr) 1993-04-22 1995-07-21 Leguern Jacques Composition régénératrice des cellules et son application en milieu médical, vétérinaire et agricole.

Also Published As

Publication number Publication date
ES2245022T3 (es) 2005-12-16
NZ337504A (en) 2001-01-26
AU743346B2 (en) 2002-01-24
DE69830176D1 (de) 2005-06-16
HUP0001342A2 (hu) 2000-09-28
CN1248915A (zh) 2000-03-29
EP1001771A1 (en) 2000-05-24
IS5152A (is) 1999-08-11
IL131267A0 (en) 2001-01-28
AU6270398A (en) 1998-09-08
NO321663B1 (no) 2006-06-19
EP1001771B1 (en) 2005-05-11
ATE295169T1 (de) 2005-05-15
EE9900346A (et) 2000-02-15
EP1001771A4 (en) 2000-09-27
US5977143A (en) 1999-11-02
HUP0001342A3 (en) 2000-10-30
KR20000071053A (ko) 2000-11-25
LV12450B (en) 2000-10-20
LT99101A (en) 2000-03-27
CA2280685A1 (en) 1998-08-20
JP3497513B2 (ja) 2004-02-16
CA2280685C (en) 2004-06-29
PL335419A1 (en) 2000-04-25
SK110599A3 (en) 2000-11-07
DE69830176T2 (de) 2006-01-26
BR9807370A (pt) 2000-03-14
NO993921D0 (no) 1999-08-13
TR199901958T2 (xx) 1999-12-21
LV12450A (lv) 2000-04-20
WO1998035676A1 (en) 1998-08-20
LT4661B (lt) 2000-05-25
JP2000513737A (ja) 2000-10-17

Similar Documents

Publication Publication Date Title
ID29181A (id) Kombinasi formoterol dan garam tiotropium
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
MX171191B (es) Composiciones farmaceuticas de glipizida
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
GR3017855T3 (en) Use of lithium in the treatment or prophylaxis of Molluscum contagiosum.
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
NO20014361D0 (no) Medikament mot dysmenorrhea og premenstruelt syndrom
AR012638A1 (es) Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional
SE8804640L (sv) Laekemedel omfattande cyklolinopeptide a
WO1998035676B1 (en) A medicament against infertility and for increasing fertility
SE8903117D0 (sv) Laekemedel omfattande antamanid
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.

Legal Events

Date Code Title Description
MK1K Patent expired